Evidence map›Paper›PMID 28637883›Full record

ArticleThe Journal of experimental medicine2017

Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.

Adam J Mead, Wen Hao Neo, Nikolaos Barkas, Sahoko Matsuoka, Alice Giustacchini, Raffaella Facchini, Supat Thongjuea, Lauren Jamieson, Christopher A G Booth, Nicholas Fordham and 12 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Leukemic Stem Cells and Hematological Malignancies.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells.Frontiers in cell and developmental biology · 2022
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 4 countries.

Adam J MeadHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK adam.mead@imm.ox.ac.uk.ORCID http://orcid.org/0000-0001-8522-1002
Wen Hao NeoHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6827-3027
Nikolaos BarkasHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-4675-0718
Sahoko MatsuokaDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
Alice GiustacchiniHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8733-8594
Raffaella FacchiniHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6026-6893
Supat ThongjueaHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Lauren JamiesonHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Christopher A G BoothHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3841-6637
Nicholas FordhamHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-7830-8465
Cristina Di GenuaHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3777-9578
Deborah AtkinsonHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Onima ChowdhuryHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8150-4088
Emmanouela RepapiComputational Biology Research Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8085-0731
Nicki GrayComputational Biology Research Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-9149-0831
Shabnam KharaziDepartment of Medicine Huddinge, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
Sally-Ann ClarkHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-1720-7975
Tiphaine BouriezHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-8574-6068
Petter WollHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2340-2526
Toshio SudaCancer Science Institute, National University of Singapore, Singapore.
Claus NerlovMedical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-0544-735X
Sten Eirik W JacobsenHaematopoietic Stem Cell Biology Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK sten.eirik.jacobsen@ki.se.ORCID http://orcid.org/0000-0002-1362-3659
University of Oxford · GBKarolinska Institutet · SEKarolinska University Hospital · SENational Institute of Infectious Diseases · JPNational University of Singapore · SG

Funding

Medical Research Council G0501838Medical Research Council G0701761Medical Research Council G0801073Medical Research Council G0900892Medical Research Council G0902418Medical Research Council MC_PC_12020Medical Research Council MC_UU_00016/5Medical Research Council MC_UU_00016/7Medical Research Council MC_UU_12009/5Medical Research Council MC_UU_12009/7Medical Research Council MR/L006340/1Medical Research Council MR/M00919X/1Wellcome TrustWorldwide Cancer Research 11-0724
6 · The paper itself

Abstract

Although previous studies suggested that the expression of FMS-like tyrosine kinase 3 (Flt3) initiates downstream of mouse hematopoietic stem cells (HSCs),

Indexed as

MutationAnimalsAnti-Inflammatory Agents, Non-SteroidalBone Marrow CellsBone Marrow TransplantationCell ProliferationCells, CulturedEtanerceptfms-Like Tyrosine Kinase 3Gene Expression ProfilingHematopoietic Stem CellsMesenchymal Stem CellsMice, Inbred C57BLMice, TransgenicReverse Transcriptase Polymerase Chain ReactionSingle-Cell AnalysisAnti-Inflammatory Agents, Non-SteroidalEtanerceptFLT3 protein, humanfms-Like Tyrosine Kinase 3Tumor Necrosis Factor-alpha

Identifiers

PMID28637883
PMCPMC5502426
OpenAlexW2662412013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.